Abstract
Get full access to this article
View all access options for this article.
References
1.
Patsner
B
. Pharmacy compounding of bioidentical hormone replacement therapy (BHRT): a proposed new approach to justify FDA regulation of these prescription drugs . Food Drug Law J
2008 ;63 (2 ):459 –91 .
2.Compounded menopausal hormone therapy questions and answers: FDA takes action against compounded bioidentical hormones . US Food and Drug Administration . Texte publié sur le site:www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/PharmacyCompounding/ucm183088.htm#MenopausalHormoneTherapy (consulté le 23 juin 2010 ).
3.Medline Plus (Merriam-Webster) . Bioidentical definition . Texte publié sur le site:www.merriam-webster.com/medlineplus/bioidentical (consulté le 16 juillet 2010 ).
4.Tabers Cyclopedic Medical Dictionary . Bioidentical definition . Texte publié sur le site:www.credoreference.com/entry/tcmd/bioidentical (consulté le 16 juillet 2010 ).
5.North American Menopause Society . Estrogen and progestogen use in postmenopausal women: 2010 position statement . Menopause
2010 ;17 (2 ):242 –55 .
6.The Endocrine Society Position Statement: bioidentical hormones . Texte publié sur le site:www.endosociety.org/advocacy/policy/upload/BH_Position_Statement_final_10_25_06_w_Header.pdf (consulté le 22 juin 2010 ).
7.American Congress of Obstetricians and Gynecologists . Committee Opinion #322: compounded bioidentical hormones . Obstet Gynecol
2005 ;106 (5 Pt 1 ):1139 –40 .